Try our Advanced Search for more refined results

KaloBios Vows No Predatory Drug Pricing After Bankruptcy

By Matthew Guarnaccia (April 11, 2016, 4:34 PM EDT) -- Pharmaceutical company KaloBios on Monday promised it wouldn't engage in price-gouging or other predatory pricing of its drugs, vowing instead to focus on affordability for patients and payers in the wake of former CEO Martin Shkreli's firing and the company's bankruptcy filing....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!